FDA

Will OMB Make the Right Decision on Menu Labeling?

Will OMB Make the Right Decision on Menu Labeling?

Requiring grocery stores to display calories may be too costly for its purported benefits.

Week in Review

Week in Review

HHS issues rule affecting doctor payments, judge accepts Transocean guilty plea, and more.

Improving Drug Safety Regulation after the Meningitis Outbreak

Improving Drug Safety Regulation after the Meningitis Outbreak

Congress should provide FDA with clearer authority and increased resources.

Regulatory Breakdown in the United States

Regulatory Breakdown in the United States

The Regulatory Review summarizes the work of leading scholars from the newly published book Regulatory Breakdown: The Crisis of Confidence in U.S. Regulation.

A Prescription for the FDA

A Prescription for the FDA

To solve fundamental problems, food and drug safety agency must adapt.

The Benefits of Public Advisory Committees at the FDA

The Benefits of Public Advisory Committees at the FDA

More committees with less conflicted members may increase regulatory safety.

Is the Rulemaking Process Really a Quagmire?

Is the Rulemaking Process Really a Quagmire?

Scholars laud rulemaking’s efficiency, noting it takes “remarkably little time.”

FDA Proposes Food Safety Rules

FDA Proposes Food Safety Rules

Proposed rules seek to tackle food-borne illness.

Week in Review

Week in Review

Supreme Court declines to halt temporarily the contraceptive coverage rule, FTC toughens child online privacy rule, and more.

Regulatory Opinion: Year in Review

Regulatory Opinion: Year in Review

We feature our top opinion posts from 2012.

The Regulatory Blame Game

The Regulatory Blame Game

Criticism of FDA over meningitis outbreak repeats a familiar pattern of regulatory blame.

Week in Review

Week in Review

Political leaders call for stronger gun regulation, FDA chief pushes for specialty pharmacy rules, and more.